{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:49:23Z","timestamp":1793710163289,"version":"4.6.1"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014672","name":"Vascular Anaesthesia Society of Great Britain and Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001297","name":"Royal College of Anaesthetists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001297","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015182","name":"Hope Against Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015182","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011716","name":"British Journal of Anaesthesia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011716","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjaopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["BJA Open"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.bjao.2023.100141","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T06:13:00Z","timestamp":1684303980000},"page":"100141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Opioids and opioid receptors; understanding pharmacological mechanisms as a key to therapeutic advances and mitigation of the misuse crisis"],"prefix":"10.1016","volume":"6","author":[{"given":"David G.","family":"Lambert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjao.2023.100141_bib1","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.bja.2021.02.030","article-title":"Surgery and opioids: evidence-based expert consensus guidelines on the perioperative use of opioids in the United Kingdom","volume":"126","author":"Srivastava","year":"2021","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bjao.2023.100141_bib2","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2018.18472","article-title":"Opioids for chronic noncancer pain a systematic review and meta-analysis","volume":"320","author":"Busse","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.bjao.2023.100141_bib3","first-page":"19","article-title":"From nociception to pain perception: imaging the spinal and supraspinal pathways","volume":"207","author":"Brooks","year":"2005","journal-title":"J\u00a0Anat"},{"key":"10.1016\/j.bjao.2023.100141_bib4","first-page":"CD006146","article-title":"Opioids for neuropathic pain","volume":"2013","author":"McNicol","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bjao.2023.100141_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jnr.24695","article-title":"Pain management with opioids in adults","volume":"100","author":"Montgomery","year":"2022","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.bjao.2023.100141_bib6","doi-asserted-by":"crossref","first-page":"E130","DOI":"10.46747\/cfp.6705e130","article-title":"PEER systematic review of randomized controlled trials management of chronic neuropathic pain in primary care","volume":"67","author":"Falk","year":"2021","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.bjao.2023.100141_bib7","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3390\/ph14111091","article-title":"Opioid analgesia and opioid-induced adverse effects: a review","volume":"14","author":"Paul","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bjao.2023.100141_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/bja\/aep392","article-title":"Opioid-induced hyperalgesia: a clinical challenge","volume":"104","author":"Colvin","year":"2010","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bjao.2023.100141_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2125.2012.04317.x","article-title":"Differences between opioids: pharmacological, experimental, clinical and economical perspectives","volume":"75","author":"Drewes","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bjao.2023.100141_bib10","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s40265-021-01619-6","article-title":"Difelikefalin: first approval","volume":"81","author":"Deeks","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.bjao.2023.100141_bib11","article-title":"Opioid pharmacology","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.bjao.2023.100141_bib12","series-title":"Modern anesthetics","first-page":"283","article-title":"Remifentanil and other opioids","author":"Servin","year":"2008"},{"key":"10.1016\/j.bjao.2023.100141_bib13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/bja\/aet153","article-title":"Opioids and immune modulation: more questions than answers","volume":"111","author":"Al-Hashimi","year":"2013","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bjao.2023.100141_bib14","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.3389\/fimmu.2019.02914","article-title":"Do all opioid drugs share the same immunomodulatory properties? A review from animal and human studies","volume":"10","author":"Franchi","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.bjao.2023.100141_bib15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.pnpbp.2019.02.010","article-title":"Members of the same pharmacological family are not alike: different opioids, different consequences, hope for the opioid crisis?","volume":"92","author":"Emery","year":"2019","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bjao.2023.100141_bib16","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nrd2572","article-title":"The nociceptin\/orphanin FQ receptor: a target with broad therapeutic potential","volume":"7","author":"Lambert","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bjao.2023.100141_bib17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/bjaceaccp\/mku041","article-title":"Opioid receptors","volume":"15","author":"McDonald","year":"2015","journal-title":"BJA Educ"},{"key":"10.1016\/j.bjao.2023.100141_bib18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-med-062613-093100","article-title":"Opioid receptors","volume":"67","author":"Stein","year":"2016","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.bjao.2023.100141_bib19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/pr.114.009209","article-title":"Nociceptin\/orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems","volume":"68","author":"Toll","year":"2016","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bjao.2023.100141_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/bja\/aer115","article-title":"Opioid receptor subtypes: fact or artifact?","volume":"107","author":"Dietis","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bjao.2023.100141_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0301-0082(02)00008-4","article-title":"Exploring the opioid system by gene knockout","volume":"66","author":"Kieffer","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.bjao.2023.100141_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1124\/jpet.102.046979","article-title":"Nociceptin\/orphanin FQ and its receptor \u2013 potential targets for pain therapy?","volume":"306","author":"Zeilhofer","year":"2003","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.bjao.2023.100141_bib23","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1124\/pr.112.007138","article-title":"Mu opioids and their receptors: evolution of a concept","volume":"65","author":"Pasternak","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bjao.2023.100141_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.807549","article-title":"Knock-in mouse models to investigate the functions of opioid receptors in\u00a0vivo","volume":"16","author":"Degrandmaison","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.bjao.2023.100141_bib25","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bjao.2023.100141_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/2049463720911986","article-title":"Basic opioid pharmacology an update","volume":"14","author":"James","year":"2020","journal-title":"Br J Pain"},{"key":"10.1016\/j.bjao.2023.100141_bib27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrn1431","article-title":"State-dependent opioid control of pain","volume":"5","author":"Fields","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bjao.2023.100141_bib28","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1111\/bph.12744","article-title":"Functional plasticity of the N\/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists","volume":"171","author":"Schroder","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bjao.2023.100141_bib29","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/35047086","article-title":"\u03bc-Opioid receptor desensitization by \u03b2-arrestin-2 determines morphine tolerance but not dependence","volume":"408","author":"Bohn","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bjao.2023.100141_bib30","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking beta-arrestin 2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bjao.2023.100141_bib31","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.087254","article-title":"Morphine side effects in beta-arrestin 2 knockout mice","volume":"314","author":"Raehal","year":"2005","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.bjao.2023.100141_bib32","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.tips.2020.09.009","article-title":"Critical assessment of G protein-biased agonism at the \u03bc-opioid receptor","volume":"41","author":"Gillis","year":"2020","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bjao.2023.100141_bib33","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1111\/bph.15004","article-title":"Morphine-induced respiratory depression is independent of \u03b2-arrestin2 signalling","volume":"177","author":"Kliewer","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bjao.2023.100141_bib34","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1038\/s41386-021-01054-x","article-title":"Pharmacological and genetic manipulations at the \u03bc-opioid receptor reveal arrestin-3 engagement limits analgesic tolerance and does not exacerbate respiratory depression in mice","volume":"46","author":"He","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bjao.2023.100141_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaz3140","article-title":"Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists","volume":"13","author":"Gillis","year":"2020","journal-title":"Sci Signal"},{"key":"10.1016\/j.bjao.2023.100141_bib36","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1021\/acs.biochem.1c00466","article-title":"Low intrinsic efficacy alone cannot explain the improved side effect profiles of new opioid agonists","volume":"61","author":"Stahl","year":"2022","journal-title":"Biochemistry"},{"key":"10.1016\/j.bjao.2023.100141_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev.med.55.091902.103843","article-title":"Inherited diseases involving G proteins and G protein-coupled receptors","volume":"55","author":"Spiegel","year":"2004","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.bjao.2023.100141_bib38","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1046\/j.1471-4159.2001.00362.x","article-title":"Inverse agonists and neutral antagonists at \u03bc opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence","volume":"77","author":"Wang","year":"2001","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.bjao.2023.100141_bib39","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1021\/acschemneuro.9b00067","article-title":"Discovery of \u03b4 opioid receptor full inverse agonists and their effects on restraint stress-induced cognitive impairment in mice","volume":"10","author":"Hirayama","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bjao.2023.100141_bib40","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1124\/jpet.106.118810","article-title":"Different effects of opioid antagonists on \u03bc-, \u03b4-, and \u03ba-opioid receptors with and without agonist pretreatment","volume":"321","author":"Wang","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.bjao.2023.100141_bib41","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1124\/mol.109.062208","article-title":"Modulation of silent and constitutively active nociceptin\/orphanin FQ receptors by potent receptor antagonists and Na+ ions in rat sympathetic neurons","volume":"77","author":"Mahmoud","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bjao.2023.100141_bib42","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11111","article-title":"Structure of the delta-opioid receptor bound to naltrindole","volume":"485","author":"Granier","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bjao.2023.100141_bib43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature10954","article-title":"Crystal structure of the micro-opioid receptor bound to a morphinan antagonist","volume":"485","author":"Manglik","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bjao.2023.100141_bib44","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature11085","article-title":"Structure of the nociceptin\/orphanin FQ receptor in complex with a peptide mimetic","volume":"485","author":"Thompson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bjao.2023.100141_bib45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature10939","article-title":"Structure of the human kappa-opioid receptor in complex with JDTic","volume":"485","author":"Wu","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bjao.2023.100141_bib46","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tips.2004.02.012","article-title":"Principles: receptor theory in pharmacology","volume":"25","author":"Kenakin","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bjao.2023.100141_bib47","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1124\/mol.117.108787","article-title":"A\u00a0scale of agonism and allosteric modulation for assessment of selectivity, bias, and receptor mutation","volume":"92","author":"Kenakin","year":"2017","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bjao.2023.100141_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40122-019-00143-6","article-title":"A\u00a0narrative pharmacological review of buprenorphine: a unique opioid for the treatment of chronic pain","volume":"9","author":"Gudin","year":"2020","journal-title":"Pain Ther"},{"key":"10.1016\/j.bjao.2023.100141_bib49","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1017\/erm.2012.5","article-title":"Opioid receptor heteromers in analgesia","volume":"14","author":"Costantino","year":"2012","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.bjao.2023.100141_bib50","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/21441","article-title":"G-protein-coupled receptor heterodimerization modulates receptor function","volume":"399","author":"Jordan","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bjao.2023.100141_bib51","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1074\/jbc.M109.040634","article-title":"Heterodimerization of ORL1 and opioid receptors and its consequences for N-type calcium channel regulation","volume":"285","author":"Evans","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.bjao.2023.100141_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260880","article-title":"MOP and NOP receptor interaction: studies with a dual expression system and bivalent peptide ligands","volume":"17","author":"Bird","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.bjao.2023.100141_bib53","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0022-3565(25)20227-0","article-title":"Selective blockage of delta-opioid receptors prevents the development of morphine-tolerance and dependence in mice","volume":"258","author":"Abdelhamid","year":"1991","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.bjao.2023.100141_bib54","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1111\/bph.14199","article-title":"In\u00a0vitro and in\u00a0vivo characterization of the bifunctional mu and delta opioid receptor ligand UFP-505","volume":"175","author":"Dietis","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bjao.2023.100141_bib55","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/aps.2017.14","article-title":"The opioid receptor triple agonist DPI-125 produces analgesia with less respiratory depression and reduced abuse liability","volume":"38","author":"Yi","year":"2017","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.bjao.2023.100141_bib56","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.bja.2018.06.024","article-title":"Nociceptin\/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic","volume":"121","author":"Calo","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bjao.2023.100141_bib57","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1124\/jpet.114.213694","article-title":"Cebranopadol: a novel potent analgesic nociceptin\/orphanin FQ peptide and opioid receptor agonists","volume":"349","author":"Linz","year":"2014","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.bjao.2023.100141_bib58","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/j.pain.0000000000000986","article-title":"Cebranopadol, a novel first-in-class analgesic drug candidate: first experience in patients with chronic low back pain in a randomized clinical trial","volume":"158","author":"Christoph","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.bjao.2023.100141_bib59","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/JCP.0000000000000995","article-title":"Assessment of the abuse potential of cebranopadol in nondependent recreational opioid users a phase 1 randomized controlled study","volume":"39","author":"Gohler","year":"2019","journal-title":"J\u00a0Clin Psychopharm"},{"key":"10.1016\/j.bjao.2023.100141_bib60","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/ALN.0000000000001529","article-title":"Respiratory effects of the nociceptin\/orphanin FQ peptide and opioid receptor agonist, cebranopadol, in healthy human volunteers","volume":"126","author":"Dahan","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bjao.2023.100141_bib61","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ejp.1331","article-title":"Cancer-related chronic pain: investigation of the novel analgesic drug candidate cebranopadol in a randomized, double-blind, noninferiority trial","volume":"23","author":"Eerdekens","year":"2019","journal-title":"Eur J Pain"},{"key":"10.1016\/j.bjao.2023.100141_bib62","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jpainsymman.2019.05.012","article-title":"Cebranopadol, a novel first-in-class analgesic drug candidate: first experience with cancer-related pain for up to 26 weeks","volume":"58","author":"Koch","year":"2019","journal-title":"J\u00a0Pain Symptom Manag"},{"key":"10.1016\/j.bjao.2023.100141_bib63","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/17460441.2022.2008903","article-title":"Preclinical discovery and development of oliceridine (Olinvyk \u00ae) for the treatment of post-operative pain","volume":"17","author":"Azzam","year":"2022","journal-title":"Expert Opin Drug Dis"},{"key":"10.1016\/j.bjao.2023.100141_bib64","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd3954","article-title":"Signalling bias in new drug discovery: detection, quantification and therapeutic impact","volume":"12","author":"Kenakin","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bjao.2023.100141_bib65","first-page":"927","article-title":"APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the \u03bc-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy","volume":"12","author":"Viscusi","year":"2019","journal-title":"J\u00a0Pain Res"},{"key":"10.1016\/j.bjao.2023.100141_bib66","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/papr.12801","article-title":"APOLLO-2: a randomized, placebo and active-controlled phase iii study investigating oliceridine (TRV130), a G protein-biased ligand at the \u03bc-opioid receptor, for management of moderate to severe acute pain following abdominoplasty","volume":"19","author":"Singla","year":"2019","journal-title":"Pain Pract"},{"key":"10.1016\/j.bjao.2023.100141_bib67","first-page":"3113","article-title":"ATHENA: a phase 3, open-label study of the safety and effectiveness of oliceridine (TRV130), a G-protein selective agonist at the \u03bc-opioid receptor, in patients with moderate to severe acute pain requiring parenteral opioid therapy","volume":"12","author":"Bergese","year":"2019","journal-title":"J\u00a0Pain Res"},{"key":"10.1016\/j.bjao.2023.100141_bib68","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/ALN.0000000000003441","article-title":"Benefit and risk evaluation of biased mu-receptor agonist oliceridine versus morphine","volume":"133","author":"Dahan","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bjao.2023.100141_bib69","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bjao.2023.100141_bib70","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1016\/j.cell.2022.09.041","article-title":"Molecular recognition of morphine and fentanyl by the human \u03bc-opioid receptor","volume":"185","author":"Zhuang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.bjao.2023.100141_bib71","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/1087057109357789","article-title":"Ligand detection in the allosteric world","volume":"15","author":"Kenakin","year":"2010","journal-title":"J\u00a0Biomol Screen"},{"key":"10.1016\/j.bjao.2023.100141_bib72","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1111\/bph.13823","article-title":"Allostery at opioid receptors: modulation with small molecule ligands","volume":"175","author":"Livingston","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bjao.2023.100141_bib73","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/bph.12599","article-title":"Positive allosteric modulators of the mu-opioid receptor: a novel approach for future pain medications","volume":"172","author":"Burford","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bjao.2023.100141_bib74","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2000017118","article-title":"Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects","volume":"118","author":"Kandasamy","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bjao.2023.100141_bib75","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1021\/acs.jcim.5b00388","article-title":"Ligand-based discovery of a new scaffold for allosteric modulation of the mu-opioid receptor","volume":"55","author":"Bisignano","year":"2015","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.bjao.2023.100141_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108673","article-title":"A\u00a0promising chemical series of positive allosteric modulators of the \u03bc-opioid receptor that enhance the antinociceptive efficacy of opioids but not their adverse effects","volume":"195","author":"Pryce","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bjao.2023.100141_bib77","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2018.08.021","article-title":"Epigenetic tools (The Writers, the Readers and the Erasers) and their implications in cancer therapy","volume":"837","author":"Biswas","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bjao.2023.100141_bib78","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/febs.16395","article-title":"Cancer epigenetics: promises and pitfalls for cancer therapy","volume":"289","author":"Skourti","year":"2022","journal-title":"Febs J"},{"key":"10.1016\/j.bjao.2023.100141_bib79","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1513\/AnnalsATS.201507-420MG","article-title":"Epigenetic mechanisms in asthma","volume":"13","author":"DeVries","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.bjao.2023.100141_bib80","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/joim.13045","article-title":"Epigenetic insights into multiple sclerosis disease progression","volume":"288","author":"Kular","year":"2020","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.bjao.2023.100141_bib81","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41586-019-1411-0","article-title":"Advances in epigenetics link genetics to the environment and disease","volume":"571","author":"Cavalli","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bjao.2023.100141_bib82","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1111\/bph.12865","article-title":"Epigenetics in the perioperative period","volume":"172","author":"Lirk","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bjao.2023.100141_bib83","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ejp.1674","article-title":"Time course of DNA methylation in pain conditions: from experimental models to humans","volume":"25","author":"Johansen","year":"2021","journal-title":"Eur J Pain"},{"key":"10.1016\/j.bjao.2023.100141_bib84","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2217\/epi.14.75","article-title":"Epigenetic regulation of chronic pain","volume":"7","author":"Liang","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.bjao.2023.100141_bib85","doi-asserted-by":"crossref","DOI":"10.1177\/17448069211056767","article-title":"Epigenetic modifications in neuropathic pain","volume":"17","author":"Luo","year":"2021","journal-title":"Mol Pain"},{"key":"10.1016\/j.bjao.2023.100141_bib86","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1097\/j.pain.0000000000001917","article-title":"The transition from acute to chronic pain: dynamic epigenetic reprogramming of the mouse prefrontal cortex up to 1 year after nerve injury","volume":"161","author":"Topham","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.bjao.2023.100141_bib87","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.biopsych.2019.06.027","article-title":"Epigenetic mechanisms of opioid addiction","volume":"87","author":"Browne","year":"2020","journal-title":"Biol Psychiat"},{"key":"10.1016\/j.bjao.2023.100141_bib88","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/genes12081226","article-title":"Epigenetic alterations in prescription opioid misuse: new strategies for precision pain management","volume":"12","author":"Gerra","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bjao.2023.100141_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911804","article-title":"Epigenetic modulation of opioid receptors by drugs of abuse","volume":"23","author":"Reid","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bjao.2023.100141_bib90","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1146\/annurev-pharmtox-010510-100605","article-title":"Transcriptional and epigenetic regulation of opioid receptor genes: present and future","volume":"51","author":"Wei","year":"2011","journal-title":"Annu Rev Pharmacol"},{"key":"10.1016\/j.bjao.2023.100141_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.798362","article-title":"Epigenetic and genetic factors associated with opioid use disorder: are these relevant to African American populations","volume":"12","author":"Blackwood","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bjao.2023.100141_bib92","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13148-020-00868-8","article-title":"Effect of short-term prescription opioids on DNA methylation of the OPRM1 promoter","volume":"12","author":"Sandoval-Sierra","year":"2020","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.bjao.2023.100141_bib93","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.tibs.2020.10.002","article-title":"The life cycle of the mu-opioid receptor","volume":"46","author":"Cuitavi","year":"2021","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.bjao.2023.100141_bib94","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2217\/epi-2016-0072","article-title":"Pharmacoepigenetics of the role of DNA methylation in mu-opioid receptor expression in different human brain regions","volume":"8","author":"Knothe","year":"2016","journal-title":"Epigenomics"},{"key":"10.1016\/j.bjao.2023.100141_bib95","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.biopsych.2016.09.015","article-title":"Striatal H3K27 acetylation linked to glutamatergic gene dysregulation in human heroin abusers holds promise as therapeutic target","volume":"81","author":"Egervari","year":"2017","journal-title":"Biol Psychiat"},{"key":"10.1016\/j.bjao.2023.100141_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105901","article-title":"Dual BET\/HDAC inhibition to relieve neuropathic pain: recent advances, perspectives, and future opportunities","volume":"173","author":"Romanelli","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bjao.2023.100141_bib97","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.brainres.2017.05.014","article-title":"HDAC inhibitor TSA ameliorates mechanical hypersensitivity and potentiates analgesic effect of morphine in a rat model of bone cancer pain by restoring mu-opioid receptor in spinal cord","volume":"1669","author":"Hou","year":"2017","journal-title":"Brain Res"},{"key":"10.1016\/j.bjao.2023.100141_bib98","first-page":"2803","article-title":"Histone deacetylase 2 is involved in \u03bc-opioid receptor suppression in the spinal dorsal horn in a rat model of chronic pancreatitis pain","volume":"17","author":"Liao","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.bjao.2023.100141_bib99","first-page":"22","article-title":"Novel roles of non-coding RNAs in opioid signaling and cardioprotection","volume":"4","author":"Melo","year":"2018","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.bjao.2023.100141_bib100","first-page":"763","article-title":"Epigenetic and miRNA expression changes in people with pain: a systematic review","volume":"21","author":"Polli","year":"2020","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.bjao.2023.100141_bib101","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuint.2014.03.012","article-title":"The interplay between microRNAs and histone deacetylases in neurological diseases","volume":"77","author":"Bourassa","year":"2014","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bjao.2023.100141_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.760964","article-title":"Roles of long non-coding RNAs in the development of chronic pain","volume":"14","author":"Li","year":"2021","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.bjao.2023.100141_bib103","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1471-4159.2010.07126.x","article-title":"Mining Affymetrix microarray data for long non-coding RNAs: altered expression in the nucleus accumbens of heroin abusers","volume":"116","author":"Michelhaugh","year":"2011","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.bjao.2023.100141_bib104","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02244763","article-title":"Mu-opioid receptor and alpha(2)-adrenoceptor agonist binding-sites in the postmortem brain of heroin-addicts","volume":"115","author":"Gabilondo","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bjao.2023.100141_bib105","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.molbrainres.2003.11.009","article-title":"Decreased immunodensities of micro-opioid receptors, receptor kinases GRK 2\/6 and beta-arrestin-2 in postmortem brains of opiate addicts","volume":"121","author":"Ferrer-Alcon","year":"2004","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.bjao.2023.100141_bib106","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.bp.106.031120","article-title":"Brain opioid receptor binding in early abstinence from opioid dependence: positron emission tomography study","volume":"191","author":"Williams","year":"2007","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.bjao.2023.100141_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.crneur.2021.100023","article-title":"The molecular neurobiology and neuropathology of opioid use disorder","volume":"2","author":"Blackwood","year":"2021","journal-title":"Curr Res Neurobiol"},{"key":"10.1016\/j.bjao.2023.100141_bib108","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.3389\/fimmu.2019.02904","article-title":"The role of opioid receptors in immune system function","volume":"10","author":"Eisenstein","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.bjao.2023.100141_bib109","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1111\/bph.13750","article-title":"Opioids and the immune system - friend or foe","volume":"175","author":"Plein","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bjao.2023.100141_bib110","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1191\/0269216306pm1124oa","article-title":"Opioids and the immune system","volume":"20","author":"Sacerdote","year":"2006","journal-title":"Palliat Med"},{"key":"10.1016\/j.bjao.2023.100141_bib111","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13011-020-00333-y","article-title":"A\u00a0double-edged sword of using opioids and COVID-19: a toxicological view","volume":"15","author":"Ataei","year":"2020","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1016\/j.bjao.2023.100141_bib112","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1016\/j.bja.2020.11.027","article-title":"Does opioid substitution treatment have a protective effect on the clinical manifestations of COVID-19? Comment on Br J Anaesth 2020; 125: e382\u20133","volume":"126","author":"Eagleton","year":"2021","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bjao.2023.100141_bib113","doi-asserted-by":"crossref","first-page":"E212","DOI":"10.1016\/j.bja.2021.08.022","article-title":"Therapeutic potential of long-acting opioids and opioid antagonists for SARS-CoV-2 infection","volume":"127","author":"Eagleton","year":"2021","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bjao.2023.100141_bib114","doi-asserted-by":"crossref","first-page":"E382","DOI":"10.1016\/j.bja.2020.07.004","article-title":"Opioids and the COVID-19 pandemic: does chronic opioid use or misuse increase clinical vulnerability?","volume":"125","author":"Lambert","year":"2020","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bjao.2023.100141_bib115","first-page":"756","article-title":"Opioids, gliosis and central immunomodulation","volume":"32","author":"Kadhim","year":"2018","journal-title":"J\u00a0Anesth"},{"key":"10.1016\/j.bjao.2023.100141_bib116","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fimmu.2020.00300","article-title":"Opioid receptors in immune and glial cells-implications for pain control","volume":"11","author":"Machelska","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.bjao.2023.100141_bib117","first-page":"139","article-title":"Minocycline for controlling neuropathic pain: a systematic narrative review of studies in humans","volume":"14","author":"Shin","year":"2021","journal-title":"J\u00a0Pain Res"},{"key":"10.1016\/j.bjao.2023.100141_bib118","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/bja\/aev540","article-title":"Evidence for nociceptin\/orphanin FQ (NOP) but not mu (MOP), delta (DOP) or kappa (KOP) opioid receptor mRNA in whole human blood","volume":"116","author":"Al-Hashimi","year":"2016","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bjao.2023.100141_bib119","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1213\/ane.0b013e3181617646","article-title":"Human peripheral blood mononuclear cells produce pre-pro-nociceptin\/orphanin FQ mRNA","volume":"106","author":"Williams","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bjao.2023.100141_bib120","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1111\/bph.14504","article-title":"Nociceptin\/orphanin FQ (N\/OFQ) conjugated to ATTO594: a novel fluorescent probe for the N\/OFQ (NOP) receptor","volume":"175","author":"Bird","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bjao.2023.100141_bib121","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1124\/pr.110.004135","article-title":"Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia","volume":"63","author":"Hutchinson","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bjao.2023.100141_bib122","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbi.2009.08.004","article-title":"Evidence that opioids may have toll-like receptor 4 and MD-2 effects","volume":"24","author":"Hutchinson","year":"2010","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.bjao.2023.100141_bib123","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/08923973.2022.2122500","article-title":"The potential interplay between opioid and the toll-like receptor 4 (TLR-4)","volume":"45","author":"Zare","year":"2023","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.bjao.2023.100141_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjao.2022.100010","article-title":"Opioids and cancer survival: are we looking in the wrong place?","volume":"2","author":"Giakomidi","year":"2022","journal-title":"BJA Open"},{"key":"10.1016\/j.bjao.2023.100141_bib125","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-1-62703-086-1_18","article-title":"Chimeric G proteins in fluorimetric calcium assays: experience with opioid receptors","volume":"937","author":"Camarda","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bjao.2023.100141_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268868","article-title":"A\u00a0novel bioassay to detect Nociceptin\/Orphanin FQ release from single human polymorphonuclear cells","volume":"17","author":"Bird","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.bjao.2023.100141_bib127","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nm908","article-title":"Attacking pain at its source: new perspectives on opioids","volume":"9","author":"Stein","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.bjao.2023.100141_bib128","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.bjao.2023.100141_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076682","article-title":"The Nociceptin\/Orphanin FQ system is modulated in patients admitted to ICU with sepsis and after cardiopulmonary bypass","volume":"8","author":"Thompson","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bjao.2023.100141_bib130","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1007\/s00134-008-1313-3","article-title":"The nociceptin\/orphanin FQ-NOP receptor antagonist effects on an animal model of sepsis","volume":"34","author":"Carvalho","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bjao.2023.100141_bib131","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274080","article-title":"In\u00a0vitro sepsis induces Nociceptin\/Orphanin FQ receptor (NOP) expression in primary human vascular endothelial but not smooth muscle cells","volume":"17","author":"Bird","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.bjao.2023.100141_bib132","first-page":"500","article-title":"Can opioid-free anaesthesia be personalised? A narrative review","volume":"13","author":"Goff","year":"2023","journal-title":"J\u00a0Pers Med"},{"key":"10.1016\/j.bjao.2023.100141_bib133","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.bja.2019.08.014","article-title":"Preventing opioid prescription after major surgery: a scoping review of opioid-free analgesia","volume":"123","author":"Fiore","year":"2019","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bjao.2023.100141_bib134","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/S0140-6736(22)00777-2","article-title":"Opioid-free analgesia after surgery","volume":"399","author":"Myles","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.bjao.2023.100141_bib135","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.tips.2018.10.003","article-title":"Development of new analgesics: an answer to opioid epidemic","volume":"39","author":"Yaksh","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bjao.2023.100141_bib136","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/ALN.0000000000003572","article-title":"Perioperative opioid administration: a critical review of opioid-free versus opioid-sparing approaches","volume":"134","author":"Shanthanna","year":"2021","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bjao.2023.100141_bib137","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/aas.13994","article-title":"Total opioid-free general anaesthesia can improve postoperative outcomes after surgery, without evidence of adverse effects on patient safety and pain management: a systematic review and meta-analysis","volume":"66","author":"Olausson","year":"2022","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.bjao.2023.100141_bib138","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/S0140-6736(22)00582-7","article-title":"Opioid versus opioid-free analgesia after surgical discharge: a systematic review and meta-analysis of randomised trials","volume":"399","author":"Fiore","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.bjao.2023.100141_bib139","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0140-6736(17)32513-8","article-title":"Alleviating the access abyss in palliative care and pain relief \u2013 an imperative of universal health coverage: the Lancet Commission report","volume":"391","author":"Knaul","year":"2018","journal-title":"Lancet"}],"container-title":["BJA Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772609623000205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772609623000205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:02:40Z","timestamp":1762646560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772609623000205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":139,"alternative-id":["S2772609623000205"],"URL":"https:\/\/doi.org\/10.1016\/j.bjao.2023.100141","relation":{},"ISSN":["2772-6096"],"issn-type":[{"value":"2772-6096","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioids and opioid receptors; understanding pharmacological mechanisms as a key to therapeutic advances and mitigation of the misuse crisis","name":"articletitle","label":"Article Title"},{"value":"BJA Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjao.2023.100141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author. Published by Elsevier Ltd on behalf of British Journal of Anaesthesia.","name":"copyright","label":"Copyright"}],"article-number":"100141"}}